This list is an analysis based on recent market events. It's not an investment recommendation.
Oncocross Co., Ltd. undertakes collaborative research initiatives to discover new drugs, partnering with a variety of pharmaceutical companies both within South Korea and abroad. The company offers a fresh paradigm for drug development by providing analytical insights derived from its advanced artificial intelligence drug discovery platform. Founded by Yi-Rang Kim on June 22, 2015, Oncocross operates from its headquarters located in Seoul, South Korea.
FAQs
What is Oncocross. stock price today?▼
The current price of 382150.KQ is ₩2,690 KRW — it has decreased by -7.56% in the past 24 hours. Watch Oncocross. stock price performance more closely on the chart.
What is Oncocross. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Oncocross. stocks are traded under the ticker 382150.KQ.
Is Oncocross. stock price growing?▼
382150.KQ stock has fallen by -14.47% compared to the previous week, the month change is a -28.65% fall, over the last year Oncocross. has showed a -67.71% decrease.
What is Oncocross. market cap?▼
Today Oncocross. has the market capitalization of 32.81B
What is Oncocross. revenue for the last year?▼
Oncocross. revenue for the last year amounts to 2.14B KRW.
What is Oncocross. net income for the last year?▼
382150.KQ net income for the last year is -12.97B KRW.
How many employees does Oncocross. have?▼
As of November 4, 2026, the company has 40 employees.
In which sector is Oncocross. located?▼
Oncocross. operates in the Health & Wellness sector.
When did Oncocross. complete a stock split?▼
Oncocross. has not had any recent stock splits.
Where is Oncocross. headquartered?▼
Oncocross. is headquartered in Seoul, South Korea.